Trump’s potential pharma tariffs may trigger rebound for Indian drugmakers
Donald Trump’s potential return to the White House has stirred anxiety among global businesses, but Indian pharmaceutical companies might see…
Tata Capital IPO: D-Street Debut Expected in 2025, Details Emerge
Tata Capital is gearing up for a potential Initial Public Offering (IPO) in 2025, marking what could be one of…
India, US Trade Talks ‘Constructive’; Early Deal Possible, Says India
India has characterized its ongoing trade discussions with the United States as “constructive,” signaling a potential breakthrough in long-standing efforts…
TikTok’s $14B Valuation in Trump Deal Stuns Investors: Moneycontrol Report
The proposed valuation of TikTok at $14 billion as part of a potential deal brokered during the Trump administration has…
Sensex Plunges 733 Points: Key Factors Behind Today’s Stock Market Fall
The Indian stock market experienced a significant downturn today, with the Sensex plummeting 733 points and the Nifty falling below…
Trump Aims to Curb U.S. Reliance on Semiconductor Imports
Former U.S. President Donald Trump is reportedly devising strategies to diminish America’s dependence on foreign semiconductor suppliers, according to a…
Vodafone Idea AGR Dues Case: Supreme Court Adjourns Hearing to October 6
The Supreme Court has once again adjourned the Vodafone Idea adjusted gross revenue (AGR) dues case, setting the next hearing…
Supreme Court Approves JSW’s ₹20,000 Crore Bhushan Steel Acquisition
The Supreme Court of India has cleared the path for JSW Steel to acquire Bhushan Steel in a deal valued…
UK Mulls Aid for Jaguar Land Rover Suppliers After Cyberattack
The UK government is reportedly considering providing financial assistance to Jaguar Land Rover (JLR) suppliers who have been impacted by…
Sun Pharma shares plummet after US tariffs on patented drugs.
Shares of Sun Pharmaceutical Industries, a leading Indian pharmaceutical company, experienced a significant decline, hitting a 52-week low, following the…
